Jorge Conde

speaker
469 appearances 4 recordings 1 series first heard Sep 2025 last heard 2 Sep

Jorge Conde’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Sep OctJan 26AprJulnow

Recordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.

Appearances

newest first · ▶ plays the moment
I mean, there's so much to unpack here.
So I this is ex an extraordinary advance for the treatment of in this case melanoma and hopefully over time cancers more broadly.
So let's unpack some of this if we could, Stefan.
The first one, for folks that are less familiar with cancer treatment, what is Cruda and why is ketruda alone not sufficient?
Why was this particular mRNA cancer vaccine necessary in conjunction with K Truda?
Mm-hmm.
Okay,
That's where the personalized cancer vaccine technology will make a big impact on the treatment of melanoma.
We'll come back to the personalized piece, because I think that's just fascinating, not only from a technological standpoint, but just from an operational standpoint.
So I do want to come back to that.
But let's focus on the word vaccine.
So typically, when you think of the word vaccine, it is to prevent a disease.
Here, in this context, these patients already have cancer.
cancer.
So in a sense, you are preventing something.
You're not preventing the cancer.
What you're preventing is the return of the cancer.
Which is in and of itself an extraordinary thing to think about from a therapeutic intervention perspective.
So number one, is that a fair characterization of the thing?
It's a fair characterization.
Showing 21–40 of 469 · page 2 of 24 ← Previous Next →